Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RETISERT safely and effectively. See full prescribing information for RETISERT. RETISERT (fluocinolone acetonide intravitreal implant) 0.59 mg, for intravitreal use Initial U.S. Approval: 1963
Medication labelWhy this: Advisory · dailymed-prescription
RETISERT ®is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.
- generic_name
- fluocinolone acetonide
- product_names
- Fluocinolone Acetonide
- ndc
- 24208-416, 24208-416-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en